Salon ... for failing to weed out clients who are so weak or unskilled as to pose a danger to themselves — such as Jesse Easterling, who nearly died on the mountain in 2009 as the result of an overdose of the “climber's little helper,” the steroid ...
MarketWatch The trial evaluated use of oral pomalidomide plus low-dose dexamethasone (n=302) compared with high-dose dexamethasone (n=153) in patients with relapsed and refractory multiple myeloma; according to the protocol, all patients were to have been ...
Marketwire (press release) TH-302 is currently under evaluation in two Phase 3 trials: one in combination with doxorubicin versus doxorubicin alone in patients with soft tissue sarcoma (STS), and the other in combination with gemcitabine versus gemcitabine and placebo in ... and more »
Alaska Dispatch ... for failing to weed out clients who are so weak or unskilled as to pose a danger to themselves — such as Jesse Easterling, who nearly died on the mountain in 2009 as the result of an overdose of the “climber's little helper,” the steroid ... and more »
NorthJersey.com The diagnosis of Cushing's disease is usually confirmed with hormone testing (ACTH stimulation or low dose dexamethasone suppression testing), before any treatments are administered. It is one of the most common endocrinopathies (glandular diseases) ...
EON: Enhanced Online News (press release) The first study was conducted among 750 previously untreated MM patients and compared VELCADE, doxorubicin and dexamethasone (PAD) induction followed by autologous stem cell transplant (ASCT) and single-agent VELCADE maintenance (every ...
